News
Irish expert hails Swift® device after 950 treatments conducted
9 April 2024
/ News
A leading podiatrist and business owner who has completed nearly 1000 treatments using our revolutionary Swift® device has hailed its potential as the future of treating painful skin lesions.
Emblation CEO wins prestigious life sciences honour
18 March 2024
/ News
Our co-founder Gary Beale, has won a major life sciences award recognising outstanding business leadership. With a career spanning more than 25 years, he has led the company through a series of impressive milestones.
Leading podiatrist hails Swift as most effective treatment
11 December 2023
/ News
A new research study has shown that four out of every five patients suffering from a common skin condition are likely to see successful outcomes after using our microwave technology.
Council leaders welcome Emblation at new Stirling office
8 September 2023
/ News
Emblation has moved into its stunning new £4m office in Stirling, ushering in the start of a new era. We have invested heavily in our new HQ Emblation House – which boasts a sauna, gym, chillout area and a 90-person auditorium.
Major Singapore deal sets out route for global expansion
24 July 2023
/ News
We at Emblation have partnered with one of the top aesthetic equipment distributors in Singapore to expand the global reach of our innovative microwave device.
Emblation launches major $2m US clinical trial
15 June 2023
/ News
The Emblation team is undertaking a rigorous clinical trial which could transform the fortunes of our microwave treatments in the US.
Swift® could hold key to cervical cancer treatment
7 May 2023
/ News
Technology pioneered by our Emblation team has featured in promising new research which could deliver less painful and more effective treatment for cervical cancer patients.